Swiss Hepatitis C Cohort Study (SCCS)
SCCS focuses on understanding the natural history and improving the management of hepatitis C virus (HCV) infection by following participants from across Switzerland. Adults aged at least 18 who have HCV antibodies were recruited from Basel, Bern, Geneva, Lausanne, Zurich, Lugano, Neuchâtel, and St. Gallen. As of 2020, the study has over 5,800 participants, whose median age is 42. Participants are followed up every 6 to 12 months to monitor their health and the progression of the infection.
Study design
Cohort - clinical
Number of participants at first data collection
5,829 (participants as of 2020)
Recruitment is ongoing
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2000
Primary Institutions
Hospital Neuchâtel - Pourtalès
Arud Center for Addiction Medicine (Arud Zentrum für Suchtmedizin)
Clinica Moncucco
Kantonsspital St. Gallen
Lausanne University Hospital (Centre hospitalier universitaire vaudois, CHUV)
Profile paper DOI
Funders
European Commission
Federal Department of Economic Affairs, Education and Research (EAER)
Swiss National Science Foundation (SNSF)
Ongoing?
Yes
Data types collected
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- None
- None
- Healthcare data
- Mortality data
Engagement
Keywords
Consortia and dataset groups
